Author | Sant P. Chawla, MD

Articles

Aldoxorubicin Shows Promise in Advanced Soft-Tissue Sarcoma

July 22, 2017

In this interview we discuss the phase III trial of aldoxorubicin in patients with advanced soft-tissue sarcoma, which showed improved efficacy and reduced toxicity over doxorubicin.